/Investor DB

Inovia Capital — 2017 Investments

5 investments dated 2017 · listed companies and verified rows first · show all

Resonateresonate.comin𝕏Oct 2017Acquired

Resonate provides consumer data intelligence and marketing technology solutions that enable businesses to identify and optimize engagement with target customers.

AdTechAI & Machine LearningData & InfrastructureMarketing TechReston, US

Bryan Gernert(Chief Executive Officer)inGeorge Stewart(Executive Officer)inDavid Wheatley(Executive Officer)inSara T. Fagen(Executive Officer, Director)inJohn D Brady(Director)Scott Hilleboe(Director)

Co-investorsGreycroftRevolutionThe Argentum GroupZmc

ROSS Intelligencerossintelligence.comin𝕏Seed · Oct 2017Defunct

ROSS builds AI products that augment lawyers' cognitive abilities and make legal services more accessible.

AI & Machine LearningEnterprise SoftwareLegalTechSan Francisco, US

Andrew Arruda(CEO)inPargles Dall`Oglio(Founder)inJimoh Ovbiagele(Founder)inAkash VenkatStergios Anastasiadis(stergios@rossintelligencecom)Thomas Maremaa(Growth Manager)in

Co-investorsComcast VenturesHemisphere Ventures LLCY CombinatorACE & CompanyAltos VenturesDream Maker Ventures+3 more

Sweptswept.aiin𝕏Oct 2017 · $2.5M

Swept AI provides runtime supervision, policy enforcement, and monitoring for AI assistants, agentic workflows, and customer-facing AI features, giving security teams real-time visibility and control over AI behavior.

AI & Machine LearningCybersecurityEnterprise SoftwareFuture of Work

Co-investorsID VenturesService Provider CapitalWellington ManagementAfore CapitalAnn Arbor SPARKBDC Capital Corporation+2 more

VendorHawkvendorhawk.coinJun 2017 · $1.2M

Seattle, US

Patrick Lowndes(Founder)in

Co-investorsCurious CapitalTechstarsAlliance of AngelsSocial Starts

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Camino

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.